DBV Technologies S.A. (DBVT) Insider Trading Disclosures
DBV Technologies S.A. (DBVT) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DBVT
CIK: 1613780
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: I0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Associés
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerStéphane Ménard
Audit LocationParis-La Défense, France
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-30 | 2026-09-29 | 8-K | 0001193125-26-408052 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001687078-26-000019 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0001346824-26-000213 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-29 | 4 Filing | 0001760395-26-000008 | View SEC Doc Filr Page |
| S-3ASR | 2026-07-27 | — | S-3ASR | 0001193125-26-316910 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-16 | 8-K | 0001193125-26-306222 | View SEC Doc Filr Page |
| 10-Q | 2026-07-16 | 2026-06-30 | 10-Q | 0001628280-26-048453 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-29 | 8-K | 0001193125-26-288533 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-03 | 8-K | 0001193125-26-259488 | View SEC Doc Filr Page |
| S-8 | 2026-06-04 | — | S-8 | 0001193125-26-257356 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | 8-K | 0001193125-26-255414 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001687078-26-000012 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0000919574-26-002909 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0001193125-26-220564 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-12 | — | SCHEDULE 13G/A Filing | 0001213900-26-055373 | View SEC Doc Filr Page |
| ARS | 2026-05-11 | 2025-12-31 | ARS | 0001193125-26-215668 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-11 | 2026-06-03 | DEF 14A | 0001193125-26-215657 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-04-30 | 8-K | 0001193125-26-206315 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-05 | — | SCHEDULE 13G/A Filing | 0002005369-26-000033 | View SEC Doc Filr Page |
| S-8 | 2026-05-04 | — | S-8 | 0001193125-26-204139 | View SEC Doc Filr Page |
| PRE 14A | 2026-05-01 | 2026-06-03 | PRE 14A | 0001193125-26-201523 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | 8-K | 0001193125-26-197921 | View SEC Doc Filr Page |
| 10-Q | 2026-04-30 | 2026-03-31 | 10-Q | 0001628280-26-028929 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-30 | 2025-12-31 | 10-K/A | 0001193125-26-197148 | View SEC Doc Filr Page |
| 3 | 2026-04-16 | 2025-10-30 | 3 Filing | 0001845080-26-000003 | View SEC Doc Filr Page |